+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 24 Pages
  • September 2023
  • GlobalData
  • ID: 4372840
Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Emzor Pharmaceutical Industries Ltd (Emzor), a subsidiary of Emzor Chemists Limited, is a pharmaceutical company that develops, manufactures, and markets pharmaceutical products and medical consumables. The company provides analgesics, anti-inflammatories, antibiotics, antimalarials, haematinics, vitamins, and dietary supplements. Emzor provides products in various forms such as syrups, oils, drops, and tablets, among others. The company offers its products under Emtrim, Emcillin, Ferrous, Emrozon, Paracetamol, Emzolyn, Lokmal, Maldox Fresh Seas, and Omega 3, and other brands. The company has offices in Nigeria, Liberia, India, Mali, Ghana, and Sierra Leone. Emzor is headquartered in Lagos, Nigeria.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Emzor Pharmaceutical Industries Ltd - Key Facts
  • Emzor Pharmaceutical Industries Ltd - Key Employees
  • Emzor Pharmaceutical Industries Ltd - Key Employee Biographies
  • Emzor Pharmaceutical Industries Ltd - Major Products and Services
  • Emzor Pharmaceutical Industries Ltd - History
  • Emzor Pharmaceutical Industries Ltd - Company Statement
  • Emzor Pharmaceutical Industries Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Emzor Pharmaceutical Industries Ltd - Business Description
  • Emzor Pharmaceutical Industries Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Emzor Pharmaceutical Industries Ltd - Strengths
  • Emzor Pharmaceutical Industries Ltd - Weaknesses
  • Emzor Pharmaceutical Industries Ltd - Opportunities
  • Emzor Pharmaceutical Industries Ltd - Threats
  • Emzor Pharmaceutical Industries Ltd - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Emzor Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Emzor Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Emzor Pharmaceutical Industries Ltd, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Emzor Pharmaceutical Industries Ltd, Key Facts
  • Emzor Pharmaceutical Industries Ltd, Key Employees
  • Emzor Pharmaceutical Industries Ltd, Key Employee Biographies
  • Emzor Pharmaceutical Industries Ltd, Major Products and Services
  • Emzor Pharmaceutical Industries Ltd, History
  • Emzor Pharmaceutical Industries Ltd, Subsidiaries
  • Emzor Pharmaceutical Industries Ltd, Key Competitors
  • Emzor Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Emzor Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Emzor Pharmaceutical Industries Ltd, Recent Deals Summary
List of Figures
  • Emzor Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Emzor Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Glaxosmithkline Nigeria Limited
  • Afrab-Chem Ltd
  • Swiss Pharma Nigeria Ltd
  • Oculus PharmaCare Ltd
  • May & Baker Nigeria PLC